Although in vitro and in vivo experiments suggested a positive correlation of EGFR and JNK activation with glioma grades [36,40], Li et al. revealed that 80% of EGFR-negative glioblastoma samples showed JNK activation [40]. The gene discussed is MAPK8; the disease is glioblastoma.